Exercise or psychological therapy work better than medications to reduce cancer-related fatigue and should be recommended first to patients, according to a Wilmot Cancer Institute–led study published in JAMA Oncology.
The largest study to date of memory and cognition problems related to chemotherapy shows that women with breast cancer report substantial issues lasting as long as six months after treatment.
Researchers at the University’s Wilmot Cancer Institute and Roswell Park in Buffalo have discovered a possible new tool for predicting whether prostate cancer will reoccur following surgery based on the expression patterns of four genes.
University researchers hope to improve the odds of surviving acute myeloid leukemia by loading a promising compound into nanoparticles that will target the inner recesses of bone marrow where leukemia stem cells lurk.
Medical Center researchers have shown for the first time how cancer-causing mutations control and alter the way cancer cells biosynthesize and replicate.
Neuroblastoma is one of the most common and deadly of childhood cancers, and Medical Center researchers have discovered that aggressive forms of the cancer contain a specific protein in their cells’ nuclei not found in more benign cases.
A study from the Wilmot Cancer Institute is believed to be the first to examine how leukemia stem cells change over time, and the first to look for several known gene biomarkers simultaneously.
Largely unreported in 2006 was the remarkable story of three Rochester virologists whose innovation, dedication, and perseverance resulted in the key breakthrough that lies at the heart of the first vaccine targeting the leading cause of cervical cancer.
Wilmot Cancer Institute discovered something simple and inexpensive to reduce pain and tingling in hands and feet due to chemotherapy—exercise.